These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 27661015)
1. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Demir M; Grünewald F; Lang S; Schramm C; Bowe A; Mück V; Kütting F; Goeser T; Steffen HM Medicine (Baltimore); 2016 Sep; 95(38):e4602. PubMed ID: 27661015 [TBL] [Abstract][Full Text] [Related]
2. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Suh B; Park S; Shin DW; Yun JM; Yang HK; Yu SJ; Shin CI; Kim JS; Ahn E; Lee H; Park JH; Cho B Hepatology; 2015 Apr; 61(4):1261-8. PubMed ID: 25502481 [TBL] [Abstract][Full Text] [Related]
3. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic. Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia. Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248 [TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119 [TBL] [Abstract][Full Text] [Related]
6. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy. Song BG; Sinn DH; Chi S; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1447-1452. PubMed ID: 30063482 [TBL] [Abstract][Full Text] [Related]
7. A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Chiang HH; Lee CM; Hu TH; Hung CH; Wang JH; Lu SN; Lai HC; Su WP; Lin CH; Peng CY; Chen CH Liver Int; 2018 Nov; 38(11):1997-2005. PubMed ID: 29797410 [TBL] [Abstract][Full Text] [Related]
8. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. Tamaki N; Kurosaki M; Matsuda S; Muraoka M; Yasui Y; Suzuki S; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Asahina Y; Izumi N J Gastroenterol; 2014 Nov; 49(11):1495-503. PubMed ID: 24337828 [TBL] [Abstract][Full Text] [Related]
9. Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song K; Han KH Medicine (Baltimore); 2016 May; 95(20):e3434. PubMed ID: 27196449 [TBL] [Abstract][Full Text] [Related]
10. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy. Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933 [TBL] [Abstract][Full Text] [Related]
11. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294 [TBL] [Abstract][Full Text] [Related]
12. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. Li X; Xu H; Gao P Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693 [TBL] [Abstract][Full Text] [Related]
13. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
14. Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study. Chen CL; Chang WC; Yi CH; Hung JS; Liu TT; Lei WY; Hsu CS J Formos Med Assoc; 2019 Feb; 118(2):628-635. PubMed ID: 30122312 [TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer. Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638 [TBL] [Abstract][Full Text] [Related]
17. One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Tseng TC; Choi J; Nguyen MH; Peng CY; Siakavellas S; Papatheodoridis G; Wang CC; Lim YS; Lai HC; Trinh HN; Wong C; Wong C; Zhang J; Li J; Kao JH Hepatol Int; 2021 Feb; 15(1):105-113. PubMed ID: 33547557 [TBL] [Abstract][Full Text] [Related]
18. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417 [TBL] [Abstract][Full Text] [Related]
19. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma. Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]